Lexaria Bioscience Corp.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2019
Total Assets: $2.7M
Liabilities Breakdown FY2019
Total Liabilities: $184.5K
Asset Breakdown
Total Assets: $2.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.3M | 48.0% |
| Accounts Receivable | $273.1K | 10.2% |
| Inventory | $127.4K | 4.8% |
| Property, Plant & Equipment | $591.3K | 22.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $265.1K | 9.9% |
| Other Assets | $133.1K | 5.0% |
Liabilities Breakdown
Total Liabilities: $184.5K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $136.4K | 73.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $48.1K | 26.1% |